Overview
- Legal name
- BOSTON CELL STANDARDS INC.
- Registered location
- SHARON, MA, USA
- Website
- Company website ↗
- Primary NAICS
- 325413 — In-Vitro Diagnostic Substance Manufacturing
- Latest award activity
- Sep 11, 2026
Read company summary
BOSTON CELL STANDARDS INC. is associated with UEI HA17F32KXEV8 and CAGE 48QH5 in public federal records. AcornBids currently links 1 prime award totaling $2.0M in obligations to this entity. Its largest recorded federal customer by obligations is Department of Health and Human Services. Its recorded federal awards include work classified as Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology). These categories describe the loaded award records, not a complete list of company capabilities. Its primary SAM.gov NAICS is 325413 (In-Vitro Diagnostic Substance Manufacturing). Its public SAM.gov registration lists SHARON, MA, USA.
At a glance
Prime contract obligations across loaded award records. Obligations are not revenue or contract ceilings. Summary updated Sep 28, 2026. Refresh pending; these totals may be out of date.
Business information
Public SAM.gov registration details.
- Legal name
- BOSTON CELL STANDARDS INC.
- UEI
- HA17F32KXEV8
- CAGE
- 48QH5
- Registered address
- 35 CHERYL DR, SHARON, MA, 02067, USA
- Registration status
- Active
- Primary NAICS
- 325413 — In-Vitro Diagnostic Substance Manufacturing
- SAM activation
- Apr 14, 2026
- Initial registration
- Dec 19, 2005
- Entity start
- Nov 6, 2002
- SAM updated
- Apr 14, 2026
- Registration expires
- Apr 5, 2027
- Fiscal year end
- Dec 31
- Place of incorporation
- DE, USA
Federal award analysis
Net transaction obligations by federal fiscal period.
Transaction history is not available in the loaded data. Annual funding is not estimated from current award totals.
Recent federal awards
Prime contract awards. Select an award to review its history and source evidence.
| Award / description | Awarding agency | Obligations | Start date | End date |
|---|---|---|---|---|
| 75N91024C00087FY24 SBIR PHASE II RD CONTRACT - TOPIC 442 BOSTON CELL STANDARDS, INC. | Department of Health and Human Services | $2.0M | Sep 16, 2024 | Jan 15, 2027 |
Upcoming positioning windows
Modeled recompete windows are estimates, not announced solicitations or guarantees.
Registration, certifications & contacts
| Registration evidence | Date |
|---|---|
| SAM updated | Apr 14, 2026 |
| Source loaded | Sep 26, 2026 |
| Initial registration | Dec 19, 2005 |
| Entity start | Nov 6, 2002 |
Registration classifications: Small Business. These are separate from the reported certificates above.
| Industry | Reported size status |
|---|---|
| 325413 — In-Vitro Diagnostic Substance Manufacturing | Not reported |
| 541714 — Research and Development in Biotechnology (except Nanobiotechnology) | Not reported |
| 541715 — Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) | Not reported |
| Contact | Role | Published contact methods | Evidence | Source date |
|---|---|---|---|---|
| STEVEN BOGEN | Government business | Contact method not published | SAM registration | Not available |
| STEVEN BOGEN | Alternate government business | Contact method not published | SAM registration | Not available |
| STEVEN BOGEN | Electronic business | Contact method not published | SAM registration | Not available |
| STEVEN BOGEN | Alternate electronic business | Contact method not published | SAM registration | Not available |
Registered industries
- 325413 — In-Vitro Diagnostic Substance Manufacturing
- 541714 — Research and Development in Biotechnology (except Nanobiotechnology)
- 541715 — Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Registration classifications and published certificates do not by themselves establish eligibility for a particular solicitation. View SAM source
Related companies worth researching
Explore the customer, work and award-size evidence behind each match.
Data coverage and methodology
Sources: SAM.gov registration, USAspending awards and transactions, and linked supporting records. Prime contract obligations, IDV ceilings and assistance amounts are kept separate. Missing records are not zero activity. Company claims are labeled separately. Recompete signals are rule-based scores out of 100. Positioning windows are AcornBids estimates.
No official subaward rows are loaded, so Acorn does not claim known teaming relationships.
Recently viewed companies
Keep your research moving
Save this company, track changes, and evaluate upcoming work against your targets.
Save to my research Find my fit